Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab

Fig. 1

Fundus photographs of a patient in the retinal detachment group. a An eye of an infant with aggressive posterior retinopathy of prematurity (APROP) before intravitreal ranibizumab (IVR) treatment. The iris neovascularizations were observed clearly. b A fundus photograph of the same eye before IVR in which retinal hemorrhage and thick preretinal hemorrhage can be seen. c The iris neovascularizations regressed after two weeks of IVR. d Fibrosis is seen in the fundus after two weeks of IVR. e No iris neovascularizations were observed after 25 days of IVR. f Then, 25 days after the first IVR, tractional retinal detachment occurred

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us